Steiner T, Junker U, Wunderlich H, Knöfel B, Schlichter A, Schubert J
Klinik und Poliklinik für Urologie, Friedrich-Schiller-Universität Jena.
Urologe A. 1998 May;37(3):294-8. doi: 10.1007/s001200050187.
We investigated the immunomodulatory capacity of cytokines produced by renal cell carcinoma in vitro by analyzing their effects on mitogen-induced T-lymphocyte blast cell transformation. All of the tested 70 cell cultures, derived from 70 tumor areas in 33 patients, had immunomodulatory capacity. In addition to suppression in the lymphocyte transformation test (max. 44/70; 63%) there was also superinduction (max. 37/70; 53%). We found no significant correlation with the stage and grade of primary tumors. However, the suppression of mitogen-induced T-lymphocyte blast cell transformation was significant in multifocal tumors (0.08% TCM, P < 0.001) and non-significant in metastatic tumors. The production of the assayed cytokines IL-6, IL-10, IL-11, and TGF beta 1 was variable and there was no significant correlation to the immunomodulatory capacity of the tumors.
我们通过分析肾细胞癌产生的细胞因子对丝裂原诱导的T淋巴细胞母细胞转化的影响,在体外研究了其免疫调节能力。来自33例患者70个肿瘤区域的所有70个受试细胞培养物均具有免疫调节能力。除了在淋巴细胞转化试验中有抑制作用(最多44/70;63%)外,还有超诱导作用(最多37/70;53%)。我们发现其与原发性肿瘤的分期和分级无显著相关性。然而,丝裂原诱导的T淋巴细胞母细胞转化的抑制在多灶性肿瘤中显著(0.08%的转化系数,P<0.001),而在转移性肿瘤中不显著。所检测的细胞因子IL-6、IL-10、IL-11和转化生长因子β1的产生情况各不相同,且与肿瘤的免疫调节能力无显著相关性。